Dr Hilary Jones has shed light on a new weight loss pill, Orforglipron, which could soon be available in the UK. Manufactured by Eli Lilly, the drug works by lowering blood sugar levels, slowing food digestion, and reducing appetite. A recent study indicates that Orforglipron is effective for sustaining weight loss, particularly for individuals transitioning from weight loss injections. Users can expect to maintain approximately 75% of the weight they initially lost.
How Orforglipron works
Orforglipron belongs to a class of drugs known as GLP-1 receptor agonists, which mimic a natural hormone that regulates appetite and blood sugar. Unlike injectable versions, this pill offers a convenient oral alternative. Dr Hilary explained that the medication helps patients keep weight off after stopping obesity jabs, addressing a common challenge in long-term weight management.
Potential drawbacks
Dr Hilary also highlighted potential downsides. The cost of the pill could be significant if taken daily, and there may be side effects such as nausea or gastrointestinal issues. He emphasised that while the pill is promising, it is not a magic solution and should be used alongside lifestyle changes. “There’s always a downside,” he noted, urging patients to consult their doctors before starting any new medication.
Study results
The study, published in a peer-reviewed journal, followed participants who had previously lost weight using injectable GLP-1 drugs. Those who switched to Orforglipron maintained an average of 75% of their weight loss over six months, compared to a significant regain in the placebo group. Researchers believe this could revolutionise weight maintenance strategies.
Availability and next steps
Orforglipron is currently awaiting regulatory approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). If approved, it could be prescribed on the NHS or privately. Dr Hilary advises that patients should weigh the benefits against potential costs and side effects, and always seek professional medical advice.
